课题基金 / 基金详情

Role of osteocalcin in the calcium metabolism disorder

Role of osteocalcin in the calcium metabolism disorder
骨钙素在钙代谢紊乱中的作用
批准号:
05454505
负责人:
KATO Yuzo
金额:
$4.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994

项目摘要

项目成果

KATO Yuzo的其他基金

相似基金

相关文献

中文摘要
翻译
钙稳态是由甲状旁腺激素、降钙素和1.25(OH)2D3相互作用控制的。结果,体内血钙水平维持在10mg%左右。除了这些激素外,一些内源性因子(糖皮质激素、胃泌素、组胺、CGRP)也被报道具有低钙效力,许多药物已被用于临床和动物实验中治疗恶性肿瘤引起的高钙血症。一些作用于中枢神经系统的药物也会在实验动物身上产生低钙血症。阿司匹林被认为是最常用的止痛抗炎药。我们在多种病理生理条件下(空腹、甲状旁腺切除术、肾上腺切除术等)详细检查了阿司匹林引起的低钙血症。我们认为其作用机制不是由抑制肠道钙吸收引起的,而是由骨内膜细胞的功能紊乱引起的。骨钙素(ostecalcin, OC)是成骨细胞生成的骨适性有机基质。我们尝试测定血液中的OC和OC段。现在我们可以用我们的方法来做。除此之外,我们还试图检测血液中的离子钙。我们在乙醚麻醉下通过眼眶穿刺取了血样。在这一步中,我们已经知道乙醚麻醉会影响离子钙水平,特别是在重麻醉条件下。在实验过程中,我们可以建立许多有用的方法,用于进一步的实验。然而,要了解OC在骨代谢中的作用,还需要更多的研究。
英文摘要
Calcium homeostasis is controlled by the interactions of parathyroid-hormone, calcitonin and 1.25(OH)2D3. As a result, the blood calcium level is maintained about 10mg% in vivo. In addition to those hormones, several endogenous factors (glucocorticoid, gastrin, histamine, CGRP) also have been reported to have hypocalcemic potency and a number of agents have been used for the treatment of malignancy-induced hypercalcemia both clinically and in animal experiments. Several drugs acting on the central nerveous system can produce hypocalcemia in experimental animals, too. Aspirin has been treated as the most frequently used analgesic-antiinflammatory agent. We examined in detail the aspirin-induced hypocalcemia under many pathophysiological conditions (fasting, thyroparathyroid-ectomy, adrenalectomy, etc. We've thought that the mechanism of action would be induced by not the inhibition of calcium absorption from the intestinal tract but the functional disorder of bone lining cells. Osteocalcin (OC) is the bone proper organic matrix made by osteoblast. We tried to determine OC and OC segment in blood. Now we can do it by our method. In addition to it, we tried to detect the ionized calcium in blood. We took the blood sample by the orbital puncture under ether anethesia. In this step, we've known that ether anesthesia affects the ionized calcium level, especially under the heavy anesthetic condition. During the experiment, we could established many useful methods to use for further experiments. More works are necessary, however, to see the role of OC on the bone metabolism.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mataki S.: "Pharmacological Application to the Study of the Formation and the Resorption Mechanism of Hard Tissues" Ishiyaku EuroAmerica, Inc., Tokyo, 133-141 (1994)
Mataki S.:“硬组织形成和吸收机制研究的药理学应用”Ishiyaku EuroAmerica, Inc.,东京,133-141 (1994)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mataki S.: "Significsance of osteocalcin in bone metabolism. In : Pharmacological Apporoach to the Study of the Formation and Resorption Mechanism of Hard Tissue. (Ogura H., ed.)" Ishiyaku Auro-America, Inc., Tokyo. 133-141 (1994)
Mataki S.:“骨钙素在骨代谢中的意义。见:硬组织形成和吸收机制研究的药理学方法。(Ogura H.,编辑)”Ishiyaku Auro-America,Inc.,东京。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
小林 泰浩: "オステオカルシン断片化に関する基礎的研究" 歯科基礎医学会雑誌. 36. 200 (1994)
小林泰宏:“骨钙素碎裂的基础研究”日本基础牙科医学会杂志 36. 200 (1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    On the custom of real estimate's transaction in the concessions and the settlements of modern China
    Study of the correlation bone in osteoclast resorption with atopic disease
    • 批准号:
      15390563
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2003
    • 负责人:
      KATO Yuzo
    • 依托单位:
    Design and application of new fluoroescent substrate against membrane-bound processing enzyme
    • 批准号:
      11557138
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      1999
    • 负责人:
      KATO Yuzo
    • 依托单位:
    Roles of metalloprotease-disintegrins in osteoclastogenesis
    • 批准号:
      09470404
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.72万
    • 财政年份:
      1997
    • 负责人:
      KATO Yuzo
    • 依托单位:
    国内基金
    海外基金
    胃癌致骨丢失通过原纤毛蛋白IFT80与CCSAP相互作用抑制osteocalcin基因转录
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2022
    • 负责人:
      汪长东
    • 依托单位:
    Osteocalcin/MiR-133a参与维生素K"促分化、抗凋亡"机制及其在预防激素型股骨头坏死中的作用
    • 批准号:
      81301572
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      高悠水
    • 依托单位: